Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

100%

4 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(50.0%)
Phase 4
2(50.0%)
4Total
Phase 3(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00445276Phase 4Completed

Symptomatic Efficacy of Diacerein in Knee Osteoarthritis

Role: lead

NCT00440661Phase 4Completed

Exploration of the Synovial Fluid Inflammation Mediators Under Diacerhein in Knee Osteoarthritis

Role: lead

NCT01009671Phase 3Unknown

Study to Evaluate the Digestive Tolerability of ART44 Versus ART®50 in Patients With Osteoarthritis of the Knee

Role: lead

NCT00451360Phase 3Completed

Chondromodulating Effect of Diacerein in Osteoarthritis of the Hip

Role: lead

All 4 trials loaded